Chemomab Therapeutics is merging in an all-stock deal to create a precision medicine leader focused on rheumatoid arthritis. The combined…
Read More

Chemomab Therapeutics is merging in an all-stock deal to create a precision medicine leader focused on rheumatoid arthritis. The combined…
Read More
Spanish biotech Telum Therapeutics has secured €18 million in a Series A round to advance its lead programme targeting hospital-acquired…
Read More